sr141716 has been researched along with Endotoxemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cinar, R; Gao, B; Godlewski, G; Gunduz-Cinar, O; Herrerias, A; Iyer, MR; Kunos, G; Lin, Y; Santos-Molina, L; Wood, CM; Zawatsky, CN | 1 |
| de La Serre, CB; Grunewald, ZI; Kirkland, R; Lee, S; Ross, M | 1 |
| Bernardi, M; Caraceni, P; Croci, T; Cutrin, J; Domenicali, M; Giannone, F; Grattagliano, I; Mastroleo, C; Perrelli, MG; Pertosa, AM; Principe, A; Trevisani, F | 1 |
| Alhouayek, M; Cani, PD; Delzenne, NM; Lambert, DM; Muccioli, GG | 1 |
| Antunes-Rodrigues, J; de Carvalho Borges, B; Elias, LL; Reis, WL; Rorato, R | 1 |
| Denhardt, G; Smith, SR; Terminelli, C | 2 |
7 other study(ies) available for sr141716 and Endotoxemia
| Article | Year |
|---|---|
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
Topics: Alcohol Drinking; Animals; Anxiety; Behavior, Animal; Cannabinoid Receptor Antagonists; Catalepsy; Cyclohexanols; Elevated Plus Maze Test; Endotoxemia; Endotoxins; Ethanol; Gastrointestinal Tract; Hypothermia, Induced; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stereoisomerism; Sulfonamides | 2021 |
Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance.
Topics: Animals; Body Weight; Cannabinoid Receptor Antagonists; Eating; Endotoxemia; Inflammation; Insulin Resistance; Lipopolysaccharides; Liver; Male; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction | 2019 |
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia.
Topics: Alanine Transaminase; Animals; Blood Pressure; Drug Evaluation, Preclinical; Endotoxemia; Lipopolysaccharides; Liver; Liver Circulation; Male; Necrosis; Neutrophil Infiltration; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant | 2009 |
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
Topics: Animals; Arachidonic Acids; Benzodioxoles; Colitis; Disease Models, Animal; Endocannabinoids; Endotoxemia; Enzyme Inhibitors; Glycerides; Humans; Indoles; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Trinitrobenzenesulfonic Acid | 2011 |
Cannabinoid CB₁ receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats.
Topics: Animals; Anorexia Nervosa; Body Weight; Brain Stem; Cell Count; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Eating; Endotoxemia; Gene Expression Regulation; Hypothalamus; Lipopolysaccharides; Male; Melanocyte-Stimulating Hormones; Microdialysis; Neurons; Oncogene Proteins v-fos; Piperidines; Pyrazoles; Radioimmunoassay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Time Factors; Tyrosine 3-Monooxygenase | 2012 |
Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
Topics: Animals; Benzoxazines; Camphanes; Cannabinoids; Cytokines; Dronabinol; Endotoxemia; Endotoxins; Interleukin-10; Interleukin-12; Interleukin-2; Ligands; Lipopolysaccharides; Male; Mice; Morpholines; Naphthalenes; Piperidines; Propionibacterium acnes; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Tumor Necrosis Factor-alpha | 2000 |
Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands.
Topics: Animals; Benzoxazines; Camphanes; Cannabinoids; Cytokines; Dose-Response Relationship, Drug; Dronabinol; Endotoxemia; Endotoxins; Injections, Intraperitoneal; Injections, Intravenous; Injections, Intraventricular; Interleukin-10; Interleukin-12; Ligands; Male; Mice; Mice, Knockout; Morpholines; Naphthalenes; Piperidines; Propionibacterium acnes; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Survival Rate; Tumor Necrosis Factor-alpha; Virulence Factors, Bordetella | 2001 |